Antibody-based single-cell technologies, such as flow cytometry, mass cytometry and CITE-seq, have become widely used in clinical diagnostics and basic research; however, their analysis is complicated by technical noise, batch effects, platform differences and restricted antibody panels. Here we present CytoVI, a probabilistic generative model for statistically rigorous unified analysis of antibody-based single-cell data. CytoVI generates informative cell embeddings, imputes missing measurements, performs differential protein expression testing and automates annotation of cells in a single probabilistic model. We applied CytoVI to build an integrated B cell maturation atlas spanning 350 proteins and identified proteins associated with immunoglobulin class-switching. In a cohort of patients with B cell non-Hodgkin lymphoma profiled by flow cytometry and CITE-seq, CytoVI uncovered disease-associated T cell states. CytoVI is available as open-source software at scvi-tools.org . CytoVI is a deep generative model for statistically rigorous analysis of antibody-based single-cell data.
No takes yet. Share an insight, caveat, or question.
Ingelfinger et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: